- Home
- Case Study Solution
Bausch & Lomb, Inc. (A) Custom Case Solution & Analysis
Evidence Brief: Bausch and Lomb Data Extraction
Financial Metrics
- Revenue Distortion: In December 1993, the Contact Lens Division shipped 25 million dollars worth of inventory to distributors. These shipments occurred in the final days of the fiscal year.
- Accounts Receivable: Days Sales Outstanding (DSO) increased from 67 days in 1992 to 84 days by the end of 1993.
- Inventory Levels: Distributors held approximately 12 months of inventory at the end of 1993, compared to a historical norm of 2 to 3 months.
- Profit Pressure: The company maintained a consistent 15 percent annual earnings growth target for over a decade.
- Stock Performance: Share prices reached a high of 58 dollars in 1993 before falling to the 30 dollar range following disclosure of the inventory issues.
Operational Facts
- Sales Strategy: A shift from direct sales to high-volume distributor sales occurred to meet quarterly targets.
- Incentive Structure: Sales managers received bonuses based strictly on shipments leaving the warehouse, regardless of whether distributors could sell the product to practitioners.
- Returns Policy: Many distributors claimed they were told they could return unsold lenses, though official policy often stated shipments were final.
- Market Geography: Issues were concentrated in the United States Contact Lens Division, though international units faced similar growth pressures.
Stakeholder Positions
- Daniel Gill (CEO): Maintained a public stance that the company met all accounting standards while privately pressuring divisions to hit aggressive numbers.
- Stephen McCluski (CFO): Defended the revenue recognition practices as being within the letter of the law during initial inquiries.
- Distributors: Reported being threatened with the loss of their distribution rights if they did not accept unwanted end-of-year shipments.
- SEC Investigators: Launched a formal probe into whether the December 1993 shipments constituted fraudulent revenue recognition.
Information Gaps
- The specific internal communications between the CEO and the Contact Lens Division head regarding the December 1993 mandate are not fully documented.
- The exact percentage of the 25 million dollars in lenses that were eventually returned or destroyed is not specified.
- The level of awareness among the Board of Directors regarding the gray market sales before the 1994 crisis remains unclear.
Strategic Analysis: Restoring Integrity and Market Position
Core Strategic Question
- How can Bausch and Lomb dismantle its toxic performance culture and repair its broken distribution channel without triggering a total collapse in investor confidence and operational liquidity?
Structural Analysis
The company is suffering from a breakdown in the Value Chain. By treating distributors as customers rather than partners, Bausch and Lomb has effectively competed against itself. The excess inventory in the channel has created a gray market where distributors sell lenses at deep discounts to clear their own balance sheets, undermining the pricing power of the Bausch and Lomb direct sales force.
The Jobs-to-be-Done for the ophthalmologist and the end consumer are being ignored. The focus has shifted entirely to internal accounting milestones. This has created a structural vulnerability where competitors with cleaner channels and better practitioner relationships can easily gain market share while Bausch and Lomb is paralyzed by inventory bloat.
Strategic Options
| Option | Rationale | Trade-offs |
|---|---|---|
| Immediate Channel Reset | Stop all shipments until channel inventory reaches 3 months. Restate 1993 earnings. | Short-term stock price collapse; high likelihood of SEC leniency for transparency. |
| Gradual Inventory Bleed | Reduce production slowly while maintaining current sales targets to mask the impact. | Prolongs the crisis; continues to alienate distributors; risks further SEC penalties. |
| Divestiture of Contact Lens Unit | Sell the division to a competitor or private equity to focus on Ray-Ban and surgical. | Eliminates the core problem but loses the highest-growth segment of the business. |